临床试验/NCT03971851

NCT03971851已完成不适用

Testing and Validation of a Novel Frailty Index in a Surgical Cohort

University of Iceland0 个研究点目标入组 50,000 人开始时间: 2005年1月1日最近更新: 2020年11月4日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: University of Iceland
入组人数: 50,000
主要终点: 30-day mortality

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

This study will validate the utility of a novel frailty index that uses ICD diagnoses to call frailty severity in a surgical cohort of patients 65 and older

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Retrospective

入排标准

年龄范围: 65 Years 至 —（Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Patients 65 years or older, undergoing any surgery at Landspitali University Hospital with an anesthesia team involved

排除标准

•No American Society of Anesthesiology classification provided

结局指标

主要结局

30-day mortality

时间窗: 30-days

Mortality within 30 days of surgery in each of the three frailty risk groups

Time to hospital readmission

时间窗: Up to 180 days

For patients surviving index hospitalization, the proportional hazard ratio of readmission between the three frailty group

次要结局

Prolonged hospital length-of stay(3 months)
Long-term mortality(Up to 14 years)

研究者

发起方

University of Iceland

申办方类型

Other

责任方

Sponsor

相似试验

已完成

不适用

Validation study of the efficacy of frailty discriminant score (FDS) in patients with urological cancersrological cancers (Prostate cancer: PC, bladder cancer: BC, upper tract urothelial carcinoma: UTUC, renal cell carcinoma: RCC) Controls (Ctrl) Subjects who participated in the general health survey in the IWAKI health promotion project between 2013 and 2018.

JPRN-UMIN000036497Hirosaki Univ. School of Med.559

已完成

不适用

AI-based Frailty Assessment Tool for Patients Undergoing Cardiac SurgeryFrailty

NCT06096922China National Center for Cardiovascular Diseases521

进行中（未招募）

不适用

Validating the Use of Frailty Measurements to Predict Care & Quality of LifeChronic Obstructive Pulmonary Disease

NCT06325241Ottawa Hospital Research Institute123

已完成

不适用

Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer

NCT01026467Wake Forest University Health Sciences45

已完成

不适用

Clinical Frailty Assessment and Postoperative Adverse Outcomes and Quality of Life in Elderly PatientsPerioperative Complications

NCT05387850Chinese PLA General Hospital12,000